(Q36057916)

English

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia

scientific article published on 9 May 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcomes after unrelated donor transplantation for childhood acute lymphoblastic leukemia (English)

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

18

object named as

Colin Steward

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

object named as

Robert F Wynn

2

0 references

author name string

Paul Veys

1

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Kwang Woo Ahn

3

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Sujith Samarasinghe

4

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Wensheng He

5

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Denise Bonney

6

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

John Craddock

7

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Jacqueline Cornish

8

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Stella M Davies

9

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Christopher C Dvorak

10

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Reggie E Duerst

11

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Thomas G Gross

12

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Neena Kapoor

13

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Carrie Kitko

14

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Robert A Krance

15

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Wing Leung

16

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Victor A Lewis

17

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

John E Wagner

19

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Paul A Carpenter

20

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Mary Eapen

21

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

language of work or name

0 references

publication date

9 May 2012

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

119

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

25

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

6155-6161

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Recent decrease in acute graft-versus-host disease in children with leukemia receiving unrelated donor bone marrow transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Acute graft-versus-host disease: differing risk with differing graft sources and conditioning intensity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Pathophysiology and treatment of graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

2 October 2017

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

11 July 2018

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3383023

23 September 2018

Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests

1 reference

https://pubmed.ncbi.nlm.nih.gov/22573402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22573402

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2012-01-405795

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

release_vw2ickzgcjaazmbohla3eenrce

1 reference

https://api.fatcat.wiki/v0/release/vw2ickzgcjaazmbohla3eenrce

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

11 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36057916&oldid=1842386460"